Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2027

Conditions
Sickle Cell Disease
Interventions
DRUG

25 mg/day zinc

25 mg of zinc as zinc gluconate taken orally once a day

DRUG

40 mg/day zinc

40 mg of zinc as zinc gluconate taken orally once a day

Trial Locations (1)

94609

RECRUITING

UCSF Benioff Children's Hospital Oakland, Oakland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

American Society of Hematology

OTHER

collaborator

Texas Children's Medical Center

UNKNOWN

collaborator

Thomas Jefferson University

OTHER

collaborator

Duke University

OTHER

lead

University of California, San Francisco

OTHER